$EDSA

Edesa Biotech, Inc.

Nasdaq · Healthcare · Pharmaceutical Preparations · Toronto

EDSA chart

What traders are saying about $EDSA

Latest posts

Edesa Biotech, Inc. news

Edesa Biotech, Inc. key financials

USD2025202420232022
Revenue––––
Net income-$7.2M-$6.2M-$8.4M-$17.5M
Diluted EPS––––
Total assets (year end)$14.7M$4.2M$7.8M$11.7M
Cash and equivalents (year end)$12.1M$1.6M–$8.3M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Edesa Biotech, Inc.

Ticker
EDSA (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Toronto
Incorporated in
British Columbia, Canada
Fiscal year end
September 30
SEC CIK
1540159
Former names
Stellar Biotechnologies, Inc.

Frequently asked questions

What exchange is Edesa Biotech, Inc. listed on?

Edesa Biotech, Inc. trades on the Nasdaq under the ticker symbol EDSA.

What industry is Edesa Biotech, Inc. in?

Edesa Biotech, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Edesa Biotech, Inc. headquartered?

Edesa Biotech, Inc.'s business address on file with the SEC is in Toronto.

When does Edesa Biotech, Inc.'s fiscal year end?

Edesa Biotech, Inc.'s fiscal year ends on September 30.

How much revenue did Edesa Biotech, Inc. report?

Edesa Biotech, Inc. reported $0 in revenue for calendar year 2021, according to its SEC filings.